EntryPoint Capital, LLC
- SEC CIK
- 0001992519
- Latest filing
- Aug 13, 2026
ACAD holding history
Acadia Pharmaceuticals Inc in every 13F filed by EntryPoint Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ACAD overviewAll 13F holders of ACADFull Q2 2026 holdings
- Shares (Q2 2026)
- 12,819
- Value
- $324.3K
- % of portfolio
- 0.1%
- Quarters held
- 10
- Since Q4 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 12,819 | $324.3K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 12,819 | $285.4K | 0.1% | +2,474+23.9% | Added | Holders |
| Q4 2025 | 10,345 | $276.3K | 0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 10,345 | $220.8K | 0.1% | +804+8.4% | Added | Holders |
| Q2 2025 | 9,541 | $205.8K | 0.1% | +9,541 | New | Holders |
| Q1 2025 | 0 | $0 | 0.0% | −26,022−100.0% | Sold out | Holders |
| Q4 2024 | 26,022 | $477.5K | 0.2% | +15,052+137.2% | Added | Holders |
| Q3 2024 | 10,970 | $168.7K | 0.1% | +3,544+47.7% | Added | Holders |
| Q2 2024 | 7,426 | $120.7K | 0.1% | +2,711+57.5% | Added | Holders |
| Q1 2024 | 4,715 | $87.2K | 0.1% | −994−17.4% | Reduced | Holders |
| Q4 2023 | 5,709 | $178.7K | 0.2% | – | No prior filing | Holders |